JP Morgan Downgrades Agilon Health to Neutral, Lowers Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill has downgraded Agilon Health (NYSE:AGL) from Overweight to Neutral and reduced the price target from $17 to $9.
January 05, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Agilon Health was downgraded by JP Morgan from Overweight to Neutral, and the price target was lowered significantly from $17 to $9.
The downgrade by a major financial institution like JP Morgan typically leads to a negative perception among investors, potentially causing a short-term decline in the stock price. The substantial decrease in the price target further suggests a bearish outlook on the company's valuation, which can influence investor sentiment and stock performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100